
Look Beyond Single-Use Prior Authorization Solutions: Jeff Hunnicutt
Jeff Hunnicutt emphasized vetting prior authorization vendors, scaling beyond single use cases, and AI's potential to streamline workflows.
As new vendors enter the prior authorization space,
At the meeting, Hunnicutt was a part of the “Oncology Innovation Showcase: Prior Authorization Solutions” session, in which he, alongside fellow panelists Glenn Balasky and Debra Patt, MD, PhD, MBA, MPH, provided an overview of available programs, vendors, and support tools to help streamline prior authorization workflows, supporting timely patient access to cancer care.
During the interview, Hunnicutt described prior authorization as a challenge affecting every practice and has intensified over the past 10 to 15 years as insurers pile on requirements. As a result, practices are often forced to outsource resources or dedicate significant full-time-equivalent hours to staff who do little else but follow up with
Hunnicutt pointed to a wave of new market entrants tackling prior authorization, many built around large language models and agentic
When evaluating vendors, Hunnicutt emphasized that practices must look beyond a single-point solution, urging the practices to interview vendors in return and assess their “appetite and aptitude” for building a broader suite of tools for their needs.
“Working with these guys, you’ve got to make sure that you're really, really diligent [about] seeing who has the ability to be able to do more than just what they're selling at that moment,” he said.
Looking ahead, Hunnicutt noted that he expects the next wave of innovation to focus on automating the back-and-forth communication between practices and insurers, much of which still happens manually by phone or digital message. He said he is particularly optimistic about advances in voice-based AI agents, ultimately freeing up staff time currently spent on administrative tasks for more direct patient care.
Related to this article








